Ready-to-use cell lines express endogenous, recombinant proteins

Ready-to-use cell lines can help facilitate research efforts. Amsbio has expanded its portfolio of stable cell lines to include some that express endogenous or recombinant proteins. They are suitable for manufacture of therapeutic and diagnostic proteins, and applications in drug screening, pharmacological research and toxicological studies. The portfolio now includes ion channels, cell signaling, phosphodiesterases, stem cell-related, fluorescent, TetR, luciferase, CRE recombinase / reporter and p53 and DNA repair gene knock-down cell lines. Amsbio LLC